High‐Sensitivity Troponin T and C‐Reactive Protein Have Different Prognostic Values in Hemo‐ and Peritoneal Dialysis Populations: A Cohort Study

Journal of the American Heart Association

  ^{1    2    3    4    5} 

[1] Department of Nephrology, Wollongong Hospital, Wollongong, New South Wales, Australia;University of Wollongong, New South Wales, Australia;Department of Renal Medicine, Liverpool Hospital, Liverpool, New South Wales, Australia;University of New South Wales, Kensington, New South Wales, Australia;The University of Sydney, Camperdown, New South Wales, Australia;Department of Cardiology, Westmead Hospital, Westmead, New South Wales, Australia;The University of Sydney, Camperdown, New South Wales, Australia;Department of Renal Medicine, Westmead Hospital, Westmead, New South Wales, Australia;The Westmead Institute for Medical Research, Westmead, New South Wales, Australia;The University of Sydney, Camperdown, New South Wales, Australia;Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia;

关键词: biomarker;    end‐stage renal disease;    major adverse cardiac event;    mortality;    risk stratification;   

DOI  :  10.1161/JAHA.117.007876

来源: publisher

【 授权许可】

Unknown